FDA Clearance

Erchonia's Lunula Laser Receives FDA Clearance 

info@erchoniaeurope.com
 

The Lunula Laser Receives FDA Clearance

I am delighted to announce that the Lunula has been FDA cleared for use in the US on Dermatophytes Trichophyton Rubrum and T. Mentagrophytes, and/or yeasts Candida Albicans.  In the commercial clinic environment, feedback also points to consistently impressive results on Psoriatic nails, Tinea Pedis and generic psoriasis on the foot. As this technology was a new concept for treating a condition like Onychomycosis, the FDA was extra vigilant with their screening process and we had to bow to their every demand.  The clearance makes all the hard work worthwhile, and provides us with even more reassurance as to the efficacy of the technology.

 
Well respected US Podiatrist, Dr Kerry Zang, presented his data, which further backs up the work carried out by Robert Sullivan in Cork, and Dermatologist, Dr Wojtiech Francuzik,  from the world famous Charite University Hospital in Berlin. Lunula remains the fastest growing laser technology in the UK & Ireland for the treatment of conditions like OM, and we will continue to grow our client base so that patients around the country receive the most effective treatment available on the market.
 
 
Print Print | Sitemap Recommend this page Recommend this page
© Jeff Horn Chiropodist / Podiatrist

This website was created using 1&1 MyWebsite.